Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia

Background: Studies related to blood type in cancer patients have been conducted extensively, but they are inclined to cancer incidence or survival rate. Meanwhile, there is limited research on Chemotherapy-Induced Nausea and Vomiting (CINV), the most disturbing side effect of chemotherapy, in relat...

Full description

Saved in:
Bibliographic Details
Main Authors: Dwi Kartika Rukmi, Muhamat Nofiyanto
Format: Article
Language:English
Published: Diponegoro University 2023-08-01
Series:Nurse Media: Journal of Nursing
Subjects:
Online Access:https://ejournal.undip.ac.id/index.php/medianers/article/view/48272
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849318735803842560
author Dwi Kartika Rukmi
Muhamat Nofiyanto
author_facet Dwi Kartika Rukmi
Muhamat Nofiyanto
author_sort Dwi Kartika Rukmi
collection DOAJ
description Background: Studies related to blood type in cancer patients have been conducted extensively, but they are inclined to cancer incidence or survival rate. Meanwhile, there is limited research on Chemotherapy-Induced Nausea and Vomiting (CINV), the most disturbing side effect of chemotherapy, in relation to blood type. Purpose: This study aimed to compare CINV frequency in cancer patients by blood groups in Yogyakarta, Indonesia. Methods: A descriptive comparative study with a cross-sectional approach was conducted purposively on 70 chemotherapy patients in two hospitals in Yogyakarta. Patients with anticipatory CINV and brain cancer (primary or metastases) were excluded. The data were collected between July and November 2020 using a sheet for patient characteristics and a filled-in diary from the first to the seventh day post-chemotherapy to collect CINV data. The descriptive statistics and Kruskal Wallis test were used to analyze the data. Results: Of 70 total samples, most of them were breast cancer (71.4%) and were in stage IV (50%). They received chemotherapy alone as their primary therapy (94.3%) and received moderate to high emetogenic agents (31.4% and 35.7%). Samples mostly had A blood type (34.3%) and had undergone chemotherapy for 3-18 months (min-max). As many as 64.6% of patients experienced CINV with a delayed type and experienced moderate severity (52.9%). The bivariate test showed no difference in CINV frequencies based on blood groups in general (p=0.068). However, based on the CINV onset, there was a significant difference in CINV frequencies in the A blood group against other blood groups (p=0.020) on the fourth post-chemotherapy day. Conclusions:Unless the fourth-day post-chemotherapy, the frequency of CINV based on blood groups showed no difference. Since CINV incidence is still high, the provision of both pharmacological and non-pharmacological therapy to treat CINV has to be given to patients after chemotherapy. Blood group factors can be considered for more extensive management, especially in delayed CINV cases.
format Article
id doaj-art-dcb5ab9609254928b293c1b57d803cd0
institution Kabale University
issn 2087-7811
2406-8799
language English
publishDate 2023-08-01
publisher Diponegoro University
record_format Article
series Nurse Media: Journal of Nursing
spelling doaj-art-dcb5ab9609254928b293c1b57d803cd02025-08-20T03:50:44ZengDiponegoro UniversityNurse Media: Journal of Nursing2087-78112406-87992023-08-0113217618710.14710/nmjn.v13i2.4827222611Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, IndonesiaDwi Kartika Rukmi0https://orcid.org/0000-0002-0335-7262Muhamat Nofiyanto1Nursing Department, Faculty of Health, Universitas Jenderal Achmad Yani Yogyakarta, IndonesiaRumah Sakit Jiwa Daerah (RSJD) dr. Amino Gondohutomo, IndonesiaBackground: Studies related to blood type in cancer patients have been conducted extensively, but they are inclined to cancer incidence or survival rate. Meanwhile, there is limited research on Chemotherapy-Induced Nausea and Vomiting (CINV), the most disturbing side effect of chemotherapy, in relation to blood type. Purpose: This study aimed to compare CINV frequency in cancer patients by blood groups in Yogyakarta, Indonesia. Methods: A descriptive comparative study with a cross-sectional approach was conducted purposively on 70 chemotherapy patients in two hospitals in Yogyakarta. Patients with anticipatory CINV and brain cancer (primary or metastases) were excluded. The data were collected between July and November 2020 using a sheet for patient characteristics and a filled-in diary from the first to the seventh day post-chemotherapy to collect CINV data. The descriptive statistics and Kruskal Wallis test were used to analyze the data. Results: Of 70 total samples, most of them were breast cancer (71.4%) and were in stage IV (50%). They received chemotherapy alone as their primary therapy (94.3%) and received moderate to high emetogenic agents (31.4% and 35.7%). Samples mostly had A blood type (34.3%) and had undergone chemotherapy for 3-18 months (min-max). As many as 64.6% of patients experienced CINV with a delayed type and experienced moderate severity (52.9%). The bivariate test showed no difference in CINV frequencies based on blood groups in general (p=0.068). However, based on the CINV onset, there was a significant difference in CINV frequencies in the A blood group against other blood groups (p=0.020) on the fourth post-chemotherapy day. Conclusions:Unless the fourth-day post-chemotherapy, the frequency of CINV based on blood groups showed no difference. Since CINV incidence is still high, the provision of both pharmacological and non-pharmacological therapy to treat CINV has to be given to patients after chemotherapy. Blood group factors can be considered for more extensive management, especially in delayed CINV cases.https://ejournal.undip.ac.id/index.php/medianers/article/view/48272blood groupcinvcanceryogyakarta
spellingShingle Dwi Kartika Rukmi
Muhamat Nofiyanto
Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia
Nurse Media: Journal of Nursing
blood group
cinv
cancer
yogyakarta
title Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia
title_full Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia
title_fullStr Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia
title_full_unstemmed Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia
title_short Chemotherapy-Induced Nausea and Vomiting (CINV) Based on Blood Types among Cancer Patients in Yogyakarta, Indonesia
title_sort chemotherapy induced nausea and vomiting cinv based on blood types among cancer patients in yogyakarta indonesia
topic blood group
cinv
cancer
yogyakarta
url https://ejournal.undip.ac.id/index.php/medianers/article/view/48272
work_keys_str_mv AT dwikartikarukmi chemotherapyinducednauseaandvomitingcinvbasedonbloodtypesamongcancerpatientsinyogyakartaindonesia
AT muhamatnofiyanto chemotherapyinducednauseaandvomitingcinvbasedonbloodtypesamongcancerpatientsinyogyakartaindonesia